Name
Osaühing Perearst Inna Viik
Registry code
10721574
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
16.01.2001 (23)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
426 667 €
98 118 €
23%
2 235 €
(estimate is approximate)
369 478 €
5
Submitted
No tax arrears
27%
25%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Inna Viik 10.04.1957 (67) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 31.07.2020 | 2020 30.03.2021 | 2021 27.06.2022 | 2022 12.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 206 630 € | 226 049 € | 247 562 € | 315 861 € | 426 667 € |
| Net profit (loss) for the period | 37 723 € | 45 198 € | 42 439 € | 50 117 € | 98 118 € |
| Profit Margin | 18% | 20% | 17% | 16% | 23% |
| Current Assets | 54 954 € | 82 997 € | 70 662 € | 91 217 € | 141 850 € |
| Fixed Assets | 95 130 € | 115 167 € | 170 620 € | 209 178 € | 249 000 € |
| Total Assets | 150 084 € | 198 164 € | 241 282 € | 300 395 € | 390 850 € |
| Current Liabilities | 16 478 € | 19 360 € | 20 039 € | 29 035 € | 21 372 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 133 606 € | 178 804 € | 221 243 € | 271 360 € | 369 478 € |
| Employees | 4 | 5 | 4 | 5 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 10 838.34 € | 11 384.2 € | - |
| 2023 Q4 | - | 19 219.91 € | 20 115.77 € | 4 |
| 2023 Q3 | - | 16 904.35 € | 17 664.15 € | 4 |
| 2023 Q2 | - | 15 094.33 € | 15 796.08 € | 6 |
| 2023 Q1 | - | 18 145.99 € | 19 089.69 € | 5 |
| 2022 Q4 | - | 13 102.1 € | 13 806.75 € | 6 |
| 2022 Q3 | - | 14 232.25 € | 14 973.46 € | 6 |
| 2022 Q2 | - | 11 626.94 € | 12 269.28 € | 4 |
| 2022 Q1 | - | 11 761.04 € | 12 434.16 € | 4 |
| 2021 Q4 | - | 9 283.32 € | 9 765.91 € | 3 |
| 2021 Q3 | - | 12 853.35 € | 13 505.1 € | 3 |
| 2021 Q2 | - | 11 668.14 € | 12 263.29 € | 3 |
| 2021 Q1 | - | 13 395.46 € | 14 125.49 € | 4 |
| 2020 Q4 | - | 11 019.71 € | 11 677.43 € | 5 |
| 2020 Q3 | - | 9 624.35 € | 10 125.88 € | 5 |
| 2020 Q2 | - | 9 084.08 € | 9 565.23 € | 4 |
| 2020 Q1 | - | 11 135.94 € | 9 065.85 € | 4 |
